Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study

Leukemia. 2020 Sep;34(9):2533-2535. doi: 10.1038/s41375-020-0964-0. Epub 2020 Jul 8.

Authors

Geneviève I C G Ector¹, Elisabeth G W Huijskens², Nicole M A Blijlevens³, Peter E Westerweel⁴

Affiliations

¹ Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands. [email protected].
² Department of Clinical Microbiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
³ Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁴ Department of Haematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Pandemics*
Pneumonia, Viral*
Prevalence
Prospective Studies
SARS-CoV-2
Severe Acute Respiratory Syndrome*